Voyageur Financial Statements From 2010 to 2025
| VYYRF Stock | USD 0.10 0.00 0.00% |
Check Voyageur Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Voyageur Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Voyageur financial statements analysis is a perfect complement when working with Voyageur Pharmaceuticals Valuation or Volatility modules.
Voyageur |
Voyageur Pharmaceuticals Company Return On Equity Analysis
Voyageur Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Voyageur Pharmaceuticals Return On Equity | -0.77 |
Most of Voyageur Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Voyageur Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Voyageur Pharmaceuticals has a Return On Equity of -0.7708. This is 96.78% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 148.65% higher than that of the company.
Voyageur Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Voyageur Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Voyageur Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Voyageur Pharmaceuticals competition to find correlations between indicators driving Voyageur Pharmaceuticals's intrinsic value. More Info.Voyageur Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Voyageur Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Voyageur Pharmaceuticals Financial Statements
Voyageur Pharmaceuticals stakeholders use historical fundamental indicators, such as Voyageur Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Voyageur Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Voyageur Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Voyageur Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Voyageur Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada. Voyageur Minerals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Voyageur Pink Sheet
Voyageur Pharmaceuticals financial ratios help investors to determine whether Voyageur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Voyageur with respect to the benefits of owning Voyageur Pharmaceuticals security.